(1.32%) 5 131.09 points
(1.19%) 38 679 points
(2.09%) 16 172 points
(-1.13%) $78.06
(5.85%) $2.15
(-0.07%) $2 308.00
(-0.60%) $26.67
(0.20%) $964.50
(-0.38%) $0.929
(-1.24%) $10.85
(-0.14%) $0.797
(0.36%) $91.46
-10.80% $ 5.50
Live Chart Being Loaded With Signals
Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve...
Stats | |
---|---|
Volumen de hoy | 24 628.00 |
Volumen promedio | 5 277.00 |
Capitalización de mercado | 120.98M |
EPS | $0 ( 2024-03-06 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.267 |
ATR14 | $0.618 (22.89%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-11 | Wilson Robert N | Buy | 506 | Common Stock |
2023-11-07 | Leheny A. Rachel | Buy | 2 000 | Common Stock |
2023-11-06 | Roberts Eric W | Buy | 2 400 | Common Stock |
2023-11-03 | Roberts Eric W | Buy | 11 249 | Common Stock |
2023-11-03 | Roberts Eric W | Buy | 3 700 | Common Stock |
INSIDER POWER |
---|
96.28 |
Last 97 transactions |
Buy: 3 103 303 | Sell: 60 672 |
Volumen Correlación
Graybug Vision, Inc. Correlación
10 Correlaciones Más Positivas | |
---|---|
VKTX | 0.939 |
INFI | 0.939 |
POWW | 0.935 |
CTMX | 0.932 |
VSTA | 0.931 |
TTCF | 0.926 |
NOTV | 0.925 |
JWEL | 0.924 |
ACET | 0.918 |
COMT | 0.917 |
10 Correlaciones Más Negativas | |
---|---|
IMMR | -0.919 |
CCRC | -0.918 |
IBEX | -0.899 |
PBFS | -0.89 |
MGI | -0.883 |
ISIG | -0.878 |
ACLX | -0.875 |
SEDG | -0.873 |
MSON | -0.866 |
RMRM | -0.857 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Graybug Vision, Inc. Correlación - Moneda/Commodity
Graybug Vision, Inc. Finanzas
Annual | 2022 |
Ingresos: | $2.96M |
Beneficio Bruto: | $2.96M (100.00 %) |
EPS: | $-319.50 |
FY | 2022 |
Ingresos: | $2.96M |
Beneficio Bruto: | $2.96M (100.00 %) |
EPS: | $-319.50 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-1.690 |
FY | 2020 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-5.25 |
Financial Reports:
No articles found.
Graybug Vision, Inc.
Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the treatment of wet age-related macular degeneration, as well as in Phase IIa clinical trial to treat diabetic macular edema. It also develops GB-102, for the treatment of diabetic retinopathy; and GB-401, an intravitreally injected implant formulation of a beta-adrenergic receptor inhibitor to treat primary open-angle glaucoma. The company was formerly known as Graybug LLC and changed its name to Graybug Vision, Inc. in 2016. Graybug Vision, Inc. was incorporated in 2011 and is based in Redwood City, California.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico